Detalles de la búsqueda
1.
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.
Cancer
; 130(7): 1061-1071, 2024 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38009662
2.
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Br J Cancer
; 130(5): 861-868, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38195887
3.
Determination of quality of life-related health utilities for surgical complications in ovarian cancer.
Gynecol Oncol
; 185: 101-107, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377761
4.
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico.
Int J Gynecol Cancer
; 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453180
5.
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
Lancet Oncol
; 24(10): e415-e423, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797647
6.
Patient Engagement With Early Stage Advance Care Planning at a Comprehensive Cancer Center.
Oncologist
; 28(6): 542-550, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36848260
7.
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol.
Int J Gynecol Cancer
; 33(6): 982-987, 2023 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37045546
8.
Implementation and outcome evaluations of a multi-site improvement program in cancer genetics.
J Genet Couns
; 32(1): 182-196, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36117454
9.
Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis.
Gynecol Oncol
; 164(3): 550-557, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34974906
10.
A Randomized, Placebo-Controlled Trial Evaluating the Single and Combined Efficacy of Radiofrequency and Hybrid Fractional Laser for Nonsurgical Aesthetic Genital Procedures in Post-Menopausal Women.
Aesthet Surg J
; 42(12): 1445-1459, 2022 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35882474
11.
Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer.
Gynecol Oncol
; 161(3): 660-667, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33867146
12.
Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer.
Gynecol Oncol
; 161(1): 56-62, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33536126
13.
Incidence of myelodysplastic syndrome and acute myeloid leukemia in patients receiving poly-ADP ribose polymerase inhibitors for the treatment of solid tumors: A meta-analysis of randomized trials.
Gynecol Oncol
; 161(3): 653-659, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33736856
14.
Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer.
Gynecol Oncol
; 162(1): 24-31, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33958211
15.
Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer.
Gynecol Oncol
; 162(1): 65-71, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838925
16.
Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.
Gynecol Oncol
; 160(3): 777-785, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563487
17.
Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
Am J Obstet Gynecol
; 225(1): 68.e1-68.e11, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33549538
18.
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort.
Am J Obstet Gynecol
; 224(3): 278.e1-278.e14, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32835719
19.
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Am J Obstet Gynecol
; 224(2): 191.e1-191.e15, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32805208
20.
Facilitated cascade testing (FaCT): a randomized controlled trial.
Int J Gynecol Cancer
; 31(5): 779-783, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33443030